Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Brazil
  4. Bolsa de Valores de Sao Paulo
  5. Fleury S.A.
  6. News
  7. Summary
    FLRY3   BRFLRYACNOR5

FLEURY S.A.

(FLRY3)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Fleury S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021

04/29/2021 | 06:21pm EDT

Fleury S.A. Announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced net income was BRL 118.612 million compared to BRL 58.719 million a year ago.


ę S&P Capital IQ 2021
All news about FLEURY S.A.
10/18Fleury S.A. entered into a purchase agreement to acquire Laboratorio Marcelo Magalhaes ..
CI
07/30Fleury to Seek Acquisitions
CI
07/29Fleury S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
07/29FLEURY S A : Earnings Release - 2Q21
PU
07/29FLEURY S A : Financial Statements - 2Q21
PU
06/24FLEURY S A : Comunicado ao Mercado
PU
04/30Fleury to Seek Acquisitions
CI
04/29FLEURY S A : Financial Statements - 1Q21
PU
04/29Fleury S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
02/25Fleury S.A. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
More news
Financials
Sales 2021 3 597 M 641 M 641 M
Net income 2021 341 M 60,8 M 60,8 M
Net Debt 2021 1 738 M 310 M 310 M
P/E ratio 2021 17,3x
Yield 2021 5,43%
Capitalization 6 029 M 1 079 M 1 074 M
EV / Sales 2021 2,16x
EV / Sales 2022 2,02x
Nbr of Employees 15 000
Free-Float 54,8%
Chart FLEURY S.A.
Duration : Period :
Fleury S.A. Technical Analysis Chart | FLRY3 | BRFLRYACNOR5 | MarketScreener
Technical analysis trends FLEURY S.A.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Last Close Price 19,02 BRL
Average target price 26,38 BRL
Spread / Average Target 38,7%
EPS Revisions
Managers and Directors
Jeane Mike Tsutsui Chief Executive Officer
JosÚ Ant˘nio de Almeida Filippo Director-Finance & Investor Relations
Marcio Pinheiro Mendes Chairman
Edgar Gil Rizzatti Head-Medical, Technical & Process
Andrea Cristina de Lima Rolim Independent Director
Sector and Competitors
1st jan.Capi. (M$)
FLEURY S.A.-29.61%1 079
SONIC HEALTHCARE LIMITED26.63%14 668
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.-14.80%7 923
NEOGENOMICS, INC.-17.44%5 466
DR. LAL PATHLABS LIMITED52.28%3 870
FULGENT GENETICS, INC.58.94%2 445